Our science

Advancing longevity research together

Explore our commitment to longevity research as we push the bounds of human healthspan.

Join our Research

Research that moves longevity forward

Science has been part of our mission from the beginning. We built our Research Team early because we believe better longevity care starts with evidence, and with asking the questions that can help people get more healthy years.

Join our Trials

Advancing science

11

in-house longevity clinical trials

Studying at scale

10K+

clinical trial participants

Leading research

9

peer-reviewed publications

Explore our active research

Explore active and ongoing clinical trials designed to uncover the true potential of longevity treatments and personalized longevity solutions for a longer, healthier life.

AgelessRx: XPRIZE Healthspan Finalist

AgelessRx advanced to the XPRIZE Healthspan Finals in August 2026, bringing a data-driven 9-agent protocol targeting muscle, cognitive, and immune function.

Microdosing GLP-1 for Longevity: What Our Trial Is Studying

AgelessRx Research

Microdosing GLP-1 for Longevity: What Our Trial Is Studying

Explore how Microdosing Semaglutide may support metabolic health, inflammation, and longevity, including what our GLP-1 trial is studying.

Sleep, Aging & Our Observational Trial

AgelessRx Research

Sleep, Aging & Our Observational Trial

Our Observational Sleep for Longevity Trial is now in analysis, exploring how sleep patterns connect to biological age.

XPRIZE Healthspan Semi-Finals: What Our 90-Day Trial Found

AgelessRx Research

AgelessRx + XPRIZE Healthspan Semi-Finals: Our 90-Day Trial Findings

AgelessRx's XPRIZE Healthspan 90-day pilot measured biological aging markers in a cohort of adults. Explore the key findings from our semi-finals longevity protocol

XPRIZE Healthspan Update: Inside AgelessRx’s Longevity Clinical Trial

XPRIZE Healthspan Update: Inside AgelessRx’s Longevity Clinical Trial

AgelessRx shares early XPRIZE Healthspan semifinal results and what they suggest about the future of personalized longevity medicine.

A man running with the following subtitle in the foreground: Inside the AgelessRx XPRIZE Trial

Inside the AgelessRx XPRIZE Trial

AgelessRx is an XPRIZE Healthspan semifinalist! Learn more about the AgelessRx XPRIZE trial and what this means for the future of aging.

Explore our Science

Read our completed trials

Discover the science driving AgelessRx. From clinical research to pioneering new therapies, our past trials have laid the foundation for solutions that have helped hundreds of thousands take charge of their long-term health.

AgelessRx Research

Canagliflozin as a Longevity Therapy: AgelessRx Trial Findings

A closer look at our Canagliflozin pilot trial, including the study design, metabolic findings, glucose response, and tolerability in healthy adults.

AgelessRx Research

Low Dose Naltrexone for Healthspan: What Our Real-World Study Found

Explore how Low Dose Naltrexone may target inflammaging and support healthspan, based on real-world findings from 5,500 participants.

AgelessRx Research

AgelessRx PEARL Trial: Rapamycin & LDN Bone Density Findings

Explore PEARL trial findings on Rapamycin, Low Dose Naltrexone, and bone density, including a notable case report, potential mechanisms, safety considerations, and the need for…

AgelessRx Research

What The AgelessRx Rapamycin Study Revealed About Bioavailability

Fat intake, gut microbiome composition, and enzyme activity may all influence Rapamycin absorption. See what our study revealed.

AgelessRx Research

LDN and NAD+ for Long COVID Fatigue: AgelessRx Trial Findings

Low Dose Naltrexone and NAD+ were tested together for Long COVID fatigue in our trial. Learn what the results showed and why the combination worked.

Acarbose Longevity Research: AgelessRx Trial Data

Our Research Team tracked Acarbose as a longevity intervention in a pilot trial. See biomarker findings, glucose data, and tolerability results.

Results of the AgelessRx PEARL Trial: An Expert Analysis

Discover the results of the PEARL trial, straight from the AgelessRx experts who led the study, and learn what this means for the future of…

Could LDN and NAD+ Offer Hope for Long COVID?

Our experts launched a study to determine the effects of Low Dose Naltrexone and NAD+ on Long COVID. The results could move us closer to…

AgelessRx Donates to Support Biology of Aging Research

Learn about AgelessRx's gift to the Michigan Medicine Division of Geriatric and Palliative Medicine Geriatrics Center.

Explore our Science

Join the journey to
better health

At AgelessRx, every trial, study, and discovery reinforces our mission of advancing longevity science and access to healthspan-enhancing treatments.

Pioneering Innovation

Every trial and study brings us closer to advancing longevity science and improving access to healthspan-enhancing care.

Lab-to-Life Results

Our scientists and clinicians use proven methods to advance longevity research and collect data that strengthens your health.

Peer-Reviewed Insights

Our research is peer-reviewed and approved by an Institutional Review Board (IRB) and follows Good Clinical Practice (GCP) standards to ensure accuracy, safety, and real-world efficacy.

Be part of the discovery

Some of the most important longevity questions still need answers. You can help us find them. Join upcoming AgelessRx research and get access to select participant benefits along the way.

Access treatments and testing for less

Get personalized clinician guidance

Unlock exclusive AgelessRx discounts

Join our Trials